Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases. BJS 2018; 105: 295-301.
Published: 23rd November 2017
Authors: H. Grut, S. Solberg, T. Seierstad, M. E. Revheim, T. S. Egge, S. G. Larsen et al.
The previously reported SECA study demonstrated a dramatic 5‐year survival improvement in patients with unresectable colorectal liver metastases (CLM) treated with liver transplantation (LT) compared with chemotherapy. The objective of this study was to assess whether immunosuppressive therapy accelerates the growth of pulmonary metastases in patients transplanted for unresectable CLM.
Chest CT scans from 11 patients in the SECA study resected for 18 pulmonary metastases were reviewed retrospectively. Tumour diameter, volume and CT characteristics were registered and tumour volume doubling time was calculated. Findings in the SECA group were compared with those of a control group consisting of 12 patients with non‐transplanted rectal cancer resected for 26 pulmonary metastases. Disease‐free survival (DFS) and overall survival (OS) after first pulmonary resection were determined.
Median doubling time based on tumour diameter and volume in the SECA and control groups were 125 and 130 days (
Patients treated by LT for unresectable CLM have a good prognosis following resection of pulmonary metastases. Doubling time did not appear to be worse with the immunosuppression used after LT.Read more
You may also be interested in
Development and evaluation of a patient‐centred measurement tool for surgeons’ non‐technical skills.
Authors: J. Yule, K. Hill, S. Yule
Notes: Valid and reliable
Authors: A. Ito, T. Ebata, Y. Yokoyama, T. Igami, T. Mizuno, J. Yamaguchi et al.
Notes: Ethanol ablation is effective
Comparison of chlorhexidine–isopropanol with isopropanol skin antisepsis for prevention of surgical‐site infection after abdominal surgery.
Authors: J. C. Harnoss, O. Assadian, A. Kramer, P. Probst, C. Müller‐Lantzsch, L. Scheerer et al.
Notes: Chlorhexidine better
Construct and criterion validity testing of the Non‐Technical Skills for Surgeons (NOTSS) behaviour assessment tool using videos of simulated operations. BJS 2018; 105: 719-727.
Authors: S. Yule, A. Gupta, D. Gazarian, A. Geraghty, D. S. Smink, J. Beard et al.
Notes: Useful for research and education
Authors: S. Pengelly, J. E. A. Berry, S. E. Herrick, D. M. Bowley, G. L. Carlson
Notes: Most closed; hernia rates similar to primary closure
Postconditioning effects of argon or xenon on early graft function in a porcine model of kidney autotransplantation.
Authors: J. De Deken, S. Rex, E. Lerut, W. Martinet, D. Monbaliu, J. Pirenne et al.
Notes: No for noble gases
Authors: R. Mirnezami, A. Ahmed
Authors: O. Peacock, M. G. Bassett, A. Kuryba, K. Walker, E. Davies, I. Anderson et al.
Notes: Avoid unnecessary delay
Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy. BJS 2018; 105: 743-750.
Authors: M. Fairweather, M. J. Cavnar, G. Z. Li, M. M. Bertagnolli, R. P. DeMatteo, C. P. Raut et al.
Notes: May help treatment planning
Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial. BJS 2018; 105: 658-662.
Authors: B. Shinkins, J. N. Primrose, S. A. Pugh, B. D. Nicholson, R. Perera, T. James et al.
Notes: Not good enough alone
Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG‐RENAPE). BJS 2018; 105: 663-667.
Authors: G. Passot, F. Dumont, D. Goéré, C. Arvieux, P. Rousset, J.‐M. Regimbeau et al.
Notes: Underestimated by laparoscopy